Itraconazole and antiretroviral therapy: strategies for empirical dosing - Author's reply. - Suppr | 超能文献

Itraconazole and antiretroviral therapy: strategies for empirical dosing - Author's reply.

作者信息

Le Thuy, Adenis Antoine, Limper Andrew, Harrison Thomas

机构信息

Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.

Centre d'Investigation Clinique Antilles Guyane, Inserm CIC1424, Centre Hospitalier de Cayenne, Cayenne, France.

出版信息

Lancet Infect Dis. 2017 Nov;17(11):1123-1124. doi: 10.1016/S1473-3099(17)30582-0.

DOI:10.1016/S1473-3099(17)30582-0

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Itraconazole and antiretroviral therapy: strategies for empirical dosing - Author's reply.

Lancet Infect Dis. 2017 Nov;17(11):1123-1124. doi: 10.1016/S1473-3099(17)30582-0.

2

Itraconazole and antiretroviral therapy: strategies for empirical dosing.

Lancet Infect Dis. 2017 Nov;17(11):1122-1123. doi: 10.1016/S1473-3099(17)30568-6.

3

Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies: an open-lable, multicenter, observational trial in a Chinese cohort.伊曲康唑作为血液恶性肿瘤发热中性粒细胞减少患者经验性抗真菌治疗的疗效和安全性：中国队列的一项开放标签、多中心、观察性研究。

Chin Med J (Engl). 2011 Nov;124(22):3670-5.

4

The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.一项在韩国进行的多中心、前瞻性、开放性、观察性研究，评估了免疫功能低下患者接受伊曲康唑口服液预防治疗时，伊曲康唑静脉制剂经验性抗真菌治疗成功率与临床参数（包括伊曲康唑血药浓度）之间的关系。

Ann Hematol. 2014 Jan;93(1):33-42. doi: 10.1007/s00277-013-1826-x. Epub 2013 Jun 27.

5

[Cross-sectional investigation of first-choice of antifungal agents in empirical and preemptive antifungal therapy for patients with hematological malignancies].[血液系统恶性肿瘤患者经验性和抢先性抗真菌治疗中抗真菌药物首选的横断面调查]

Zhonghua Xue Ye Xue Za Zhi. 2013 Jun;34(6):473-7. doi: 10.3760/cma.j.issn.0253-2727.2013.06.006.

6

[Clinical study of intravenous injecting itraconazole as empirical antifungal therapy for patients with hematological malignancies].伊曲康唑静脉注射作为恶性血液病患者经验性抗真菌治疗的临床研究

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Aug;20(4):1000-4.

7

Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.米卡芬净与静脉注射伊曲康唑作为血液系统恶性肿瘤发热性中性粒细胞减少患者经验性抗真菌治疗的疗效和安全性：一项随机、对照、前瞻性、多中心研究。

Ann Hematol. 2016 Jan;95(2):337-44. doi: 10.1007/s00277-015-2545-2. Epub 2015 Nov 24.

8

Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy.与两性霉素B相比，伊曲康唑作为血液系统恶性肿瘤患者中性粒细胞减少性发热经验性抗真菌治疗的安全性和有效性。

Onkologie. 2007 Apr;30(4):185-91. doi: 10.1159/000100055. Epub 2007 Mar 23.

9

Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.伊曲康唑可预防接受血液系统恶性肿瘤治疗的中性粒细胞减少患者发生侵袭性真菌感染：来自对3597例患者的荟萃分析的证据。

J Clin Oncol. 2003 Dec 15;21(24):4615-26. doi: 10.1200/JCO.2003.04.052.

10

Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy.一名接受伊曲康唑和抗逆转录病毒治疗的HIV感染男性患者出现非洲埃默菌感染的矛盾性恶化。

PLoS Negl Trop Dis. 2018 Mar 8;12(3):e0006173. doi: 10.1371/journal.pntd.0006173. eCollection 2018 Mar.

引用本文的文献

1

Characteristics and Prognosis of Talaromyces marneffei Infection in HIV-positive Children in Southern China.中国南方地区 HIV 阳性儿童中马尔尼菲篮状菌感染的特征和预后。

Mycopathologia. 2022 Jun;187(2-3):169-180. doi: 10.1007/s11046-021-00614-5. Epub 2022 Feb 14.